Probleme bei der Darstellung von ARIVA.DE?

  • Laden unsere Charts bei Ihnen nicht?
  • Wird unser Forum bei Ihnen nicht korrekt dargestellt?

Sie nutzen einen Adblocker, der hierfür verantwortlich ist. Hierauf hat ARIVA.DE leider keinen Einfluss. Bitte heben Sie die Blockierung von ARIVA.DE in Ihrem Adblocker auf.

Probleme bei der Darstellung von ARIVA.DE?

Mainstay Medical International plc (“Mainstay” or the “Company”): Total Voting Rights

Donnerstag, 01.12.2016 08:05


Regulatory News:

Mainstay Medical International plc

(“Mainstay” or the “Company”)

Total Voting Rights

In conformity with Regulation 20 of the Transparency (Directive 2004/109/EC) Regulations 2007, Mainstay announces that:

The total number of Ordinary Shares of nominal value €0.001 each in issue on 1 December 2016 is 6,611,952 corresponding to a total of 6,611,952 voting rights. The Company holds no Ordinary Shares in treasury.

Therefore, the figure which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the Transparency (Directive 2004/109/EC) Regulations 2007 and the Transparency Rules is 6,611,952.

Total number of Ordinary Shares outstanding   6,611,952

Total number of theoretical voting rights1


Total number of exercisable voting rights2


1 December 2016

1 The total number of theoretical voting rights (or “gross” voting rights) is calculated on the basis of all shares to which voting rights are attached, including shares whose voting rights have been suspended.

2 The total number of exercisable voting rights (or ”net” voting rights) is calculated without taking into account the shares with suspended voting rights.

View source version on

(c)Business Wire. All of the news releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.